Expression of the serine protease hepsin and clinical outcome of human endometrial cancer

Tamaki Matsuo, Keiichiro Nakamura, Norio Takamoto, Junichi Kodama, Atsushi Hongo, Fernando Abrzua, Yasutomo Nasu, Hiromi Kumon, Yuji Hiramatsu

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Hepsin is a type II transmembrane serine protease originally identified in the human liver as a cDNA clone. Hepsin was found to be significantly overexpressed in cancer samples compared to matched various tissues (e.g. prostate, renal, ovarian carcinoma). The purpose of the present study was to examine hepsin expression and to evaluate its clinicopathological significance in endometrial cancer. Patients and Methods: Hepsin expression was examined by immunohistochemisty in 34 cases with normal endometrium as a control, 11 cases with endometrial hyperplasia, and 128 cases with endometrioid adenocarcinoma. Results: Hepsin expression was found to be significantly higher in endometrial cancer compared to normal endometrium and endometrial hyperplasia. High levels of hepsin expression were associated with advanced stage (p

Original languageEnglish
Pages (from-to)159-164
Number of pages6
JournalAnticancer Research
Volume28
Issue number1 A
Publication statusPublished - Jan 2008

Fingerprint

Serine Proteases
Endometrial Neoplasms
Endometrial Hyperplasia
Endometrium
Endometrioid Carcinoma
hepsin
Prostate
Complementary DNA
Clone Cells
Carcinoma
Kidney
Liver
Neoplasms

Keywords

  • Endometrial cancer
  • Hepsin
  • Prognostic significance

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Matsuo, T., Nakamura, K., Takamoto, N., Kodama, J., Hongo, A., Abrzua, F., ... Hiramatsu, Y. (2008). Expression of the serine protease hepsin and clinical outcome of human endometrial cancer. Anticancer Research, 28(1 A), 159-164.

Expression of the serine protease hepsin and clinical outcome of human endometrial cancer. / Matsuo, Tamaki; Nakamura, Keiichiro; Takamoto, Norio; Kodama, Junichi; Hongo, Atsushi; Abrzua, Fernando; Nasu, Yasutomo; Kumon, Hiromi; Hiramatsu, Yuji.

In: Anticancer Research, Vol. 28, No. 1 A, 01.2008, p. 159-164.

Research output: Contribution to journalArticle

Matsuo, T, Nakamura, K, Takamoto, N, Kodama, J, Hongo, A, Abrzua, F, Nasu, Y, Kumon, H & Hiramatsu, Y 2008, 'Expression of the serine protease hepsin and clinical outcome of human endometrial cancer', Anticancer Research, vol. 28, no. 1 A, pp. 159-164.
Matsuo T, Nakamura K, Takamoto N, Kodama J, Hongo A, Abrzua F et al. Expression of the serine protease hepsin and clinical outcome of human endometrial cancer. Anticancer Research. 2008 Jan;28(1 A):159-164.
Matsuo, Tamaki ; Nakamura, Keiichiro ; Takamoto, Norio ; Kodama, Junichi ; Hongo, Atsushi ; Abrzua, Fernando ; Nasu, Yasutomo ; Kumon, Hiromi ; Hiramatsu, Yuji. / Expression of the serine protease hepsin and clinical outcome of human endometrial cancer. In: Anticancer Research. 2008 ; Vol. 28, No. 1 A. pp. 159-164.
@article{58c48f2e10d8419c9e15ed0e958ed0e0,
title = "Expression of the serine protease hepsin and clinical outcome of human endometrial cancer",
abstract = "Background: Hepsin is a type II transmembrane serine protease originally identified in the human liver as a cDNA clone. Hepsin was found to be significantly overexpressed in cancer samples compared to matched various tissues (e.g. prostate, renal, ovarian carcinoma). The purpose of the present study was to examine hepsin expression and to evaluate its clinicopathological significance in endometrial cancer. Patients and Methods: Hepsin expression was examined by immunohistochemisty in 34 cases with normal endometrium as a control, 11 cases with endometrial hyperplasia, and 128 cases with endometrioid adenocarcinoma. Results: Hepsin expression was found to be significantly higher in endometrial cancer compared to normal endometrium and endometrial hyperplasia. High levels of hepsin expression were associated with advanced stage (p",
keywords = "Endometrial cancer, Hepsin, Prognostic significance",
author = "Tamaki Matsuo and Keiichiro Nakamura and Norio Takamoto and Junichi Kodama and Atsushi Hongo and Fernando Abrzua and Yasutomo Nasu and Hiromi Kumon and Yuji Hiramatsu",
year = "2008",
month = "1",
language = "English",
volume = "28",
pages = "159--164",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1 A",

}

TY - JOUR

T1 - Expression of the serine protease hepsin and clinical outcome of human endometrial cancer

AU - Matsuo, Tamaki

AU - Nakamura, Keiichiro

AU - Takamoto, Norio

AU - Kodama, Junichi

AU - Hongo, Atsushi

AU - Abrzua, Fernando

AU - Nasu, Yasutomo

AU - Kumon, Hiromi

AU - Hiramatsu, Yuji

PY - 2008/1

Y1 - 2008/1

N2 - Background: Hepsin is a type II transmembrane serine protease originally identified in the human liver as a cDNA clone. Hepsin was found to be significantly overexpressed in cancer samples compared to matched various tissues (e.g. prostate, renal, ovarian carcinoma). The purpose of the present study was to examine hepsin expression and to evaluate its clinicopathological significance in endometrial cancer. Patients and Methods: Hepsin expression was examined by immunohistochemisty in 34 cases with normal endometrium as a control, 11 cases with endometrial hyperplasia, and 128 cases with endometrioid adenocarcinoma. Results: Hepsin expression was found to be significantly higher in endometrial cancer compared to normal endometrium and endometrial hyperplasia. High levels of hepsin expression were associated with advanced stage (p

AB - Background: Hepsin is a type II transmembrane serine protease originally identified in the human liver as a cDNA clone. Hepsin was found to be significantly overexpressed in cancer samples compared to matched various tissues (e.g. prostate, renal, ovarian carcinoma). The purpose of the present study was to examine hepsin expression and to evaluate its clinicopathological significance in endometrial cancer. Patients and Methods: Hepsin expression was examined by immunohistochemisty in 34 cases with normal endometrium as a control, 11 cases with endometrial hyperplasia, and 128 cases with endometrioid adenocarcinoma. Results: Hepsin expression was found to be significantly higher in endometrial cancer compared to normal endometrium and endometrial hyperplasia. High levels of hepsin expression were associated with advanced stage (p

KW - Endometrial cancer

KW - Hepsin

KW - Prognostic significance

UR - http://www.scopus.com/inward/record.url?scp=40549087264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40549087264&partnerID=8YFLogxK

M3 - Article

C2 - 18383840

AN - SCOPUS:40549087264

VL - 28

SP - 159

EP - 164

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1 A

ER -